Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Veterinary active pharmaceutical ingredients manufacturing are made by more than one reaction from raw materials. It generally becomes an active pharmaceutical ingredients through the chemical compounds. The active pharmaceutical ingredients manufacturing utilize specific standards for determining how strong it is in every drug.
This report studies and analyses global Veterinary Active Pharmaceutical Ingredients Manufacturing status and future trends, to help determine the Veterinary Active Pharmaceutical Ingredients Manufacturing market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Veterinary Active Pharmaceutical Ingredients Manufacturing, and provides market size (US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Veterinary Active Pharmaceutical Ingredients Manufacturing market size, history data 2018-2023, and forecast data 2024-2029, (US$ million)
(2) Global Veterinary Active Pharmaceutical Ingredients Manufacturing by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(3) China Veterinary Active Pharmaceutical Ingredients Manufacturing by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(4) Global Veterinary Active Pharmaceutical Ingredients Manufacturing key consuming regions, consumption value and demand structure
(5) Veterinary Active Pharmaceutical Ingredients Manufacturing industry chains, upstream, midstream and downstream
According to Latest Research, the global market for Veterinary Active Pharmaceutical Ingredients Manufacturing should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Veterinary Active Pharmaceutical Ingredients Manufacturing market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Veterinary Active Pharmaceutical Ingredients Manufacturing market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Companion Animals grew percent to account for percent of the total market sales, and Production/Food Animals grew percent.
Key Players Driving the Market:
Alivira Animal Health Ltd.
Chempro Pharma Private Ltd.
Excel Industries Ltd.
FIS - Fabbrica Italiana Sintetici S.p.A.
HIKAL Ltd.
HuBei Masteam Bio-tech
Hunan Huateng Pharmaceutical
Jiangsu Rivocean
Ofichem Group
Qilu Pharma Spain, S.A.
Menadiona
Nissan Chemical
SUANFARMA
Siflon Drugs
Shaanxi Dideu Group
Taizhou Crene Biotechnology
Zhejiang Gihi Chemicals
Vetpharma (Insud Pharma, S.L.U)
By Product Type, the market is primarily segmented into:
Antiparasitic
Anti-infectives
NSAIDs
Others
By Applications, the market is segmented into:
Companion Animals
Production/Food Animals
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
The Report Consists of The Following Points:
Chapter 1: to describe Veterinary Active Pharmaceutical Ingredients Manufacturing product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Veterinary Active Pharmaceutical Ingredients Manufacturing market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 3: China Veterinary Active Pharmaceutical Ingredients Manufacturing market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 4: Veterinary Active Pharmaceutical Ingredients Manufacturing industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2018-2029
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2018-2029
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions
1 Market Overview
1.1 Veterinary Active Pharmaceutical Ingredients Manufacturing Definition
1.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size and Forecast
1.3 China Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size and Forecast
1.4 China Percentage in Global Market
1.5 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size: China VS Global Growth Rate, 2018-2029
1.6 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Dynamics
1.6.1 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Drivers
1.6.2 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Restraints
1.6.3 Veterinary Active Pharmaceutical Ingredients Manufacturing Industry Trends
1.6.4 Veterinary Active Pharmaceutical Ingredients Manufacturing Industry Policy
2 Global Leading Players and Market Share
2.1 By Revenue of Veterinary Active Pharmaceutical Ingredients Manufacturing, Global Market Share by Company, 2018-2023
2.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Concentration Ratio
2.4 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Mergers & Acquisitions, Expansion Plans
2.5 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Major Companies Product Type
2.6 Head Office and Veterinary Active Pharmaceutical Ingredients Manufacturing Production Site of Key Manufacturer
3 China Leading Players, Market Share and Ranking
3.1 By Revenue of Veterinary Active Pharmaceutical Ingredients Manufacturing, China Market Share by Company, 2018-2023
3.2 China Veterinary Active Pharmaceutical Ingredients Manufacturing Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis
4.1 Veterinary Active Pharmaceutical Ingredients Manufacturing Industry Chain
4.2 Veterinary Active Pharmaceutical Ingredients Manufacturing Upstream Analysis
4.2.1 Veterinary Active Pharmaceutical Ingredients Manufacturing Core Raw Materials
4.2.2 Main Manufacturers of Veterinary Active Pharmaceutical Ingredients Manufacturing Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Veterinary Active Pharmaceutical Ingredients Manufacturing Production Mode
4.6 Veterinary Active Pharmaceutical Ingredients Manufacturing Procurement Model
4.7 Veterinary Active Pharmaceutical Ingredients Manufacturing Industry Sales Model and Sales Channels
4.7.1 Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Model
4.7.2 Veterinary Active Pharmaceutical Ingredients Manufacturing Typical Distributors
5 Sights by Type
5.1 Veterinary Active Pharmaceutical Ingredients Manufacturing Classification
5.1.1 Antiparasitic
5.1.2 Anti-infectives
5.1.3 NSAIDs
5.1.4 Others
5.2 By Type, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value, 2018-2029
6 Sights by Application
6.1 Veterinary Active Pharmaceutical Ingredients Manufacturing Segment by Application
6.1.1 Companion Animals
6.1.2 Production/Food Animals
6.2 By Application, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value, 2018 VS 2022 VS 2029
7.2 By Region, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value, 2018-2029
7.3 North America
7.3.1 North America Veterinary Active Pharmaceutical Ingredients Manufacturing & Forecasts, 2018-2029
7.3.2 By Country, North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Market Share
7.4 Europe
7.4.1 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Market Share
7.6 South America
7.6.1 South America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level
8.1 By Country, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size & CAGR, 2018 VS 2022 VS 2029
8.2 By Country, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value, 2018-2029
8.3 U.S.
8.3.1 U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, 2018-2029
8.3.2 By Type, U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2022 VS 2029
8.3.3 By Application, U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, 2018-2029
8.4.2 By Type, Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2022 VS 2029
8.4.3 By Application, Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2022 VS 2029
8.5 China
8.5.1 China Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, 2018-2029
8.5.2 By Type, China Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2022 VS 2029
8.5.3 By Application, China Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, 2018-2029
8.6.2 By Type, Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2022 VS 2029
8.6.3 By Application, Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, 2018-2029
8.7.2 By Type, South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2022 VS 2029
8.7.3 By Application, South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, 2018-2029
8.8.2 By Type, Southeast Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2022 VS 2029
8.8.3 By Application, Southeast Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2022 VS 2029
8.9 India
8.9.1 India Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, 2018-2029
8.9.2 By Type, India Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2022 VS 2029
8.9.3 By Application, India Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2022 VS 2029
8.10 Middle East & Africa
8.10.1 Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, 2018-2029
8.10.2 By Type, Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2022 VS 2029
8.10.3 By Application, Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2022 VS 2029
9 Company Profile
9.1 Alivira Animal Health Ltd.
9.1.1 Alivira Animal Health Ltd. Company Information, Head Office, Market Area and Industry Position
9.1.2 Alivira Animal Health Ltd. Company Profile and Main Business
9.1.3 Alivira Animal Health Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
9.1.4 Alivira Animal Health Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
9.1.5 Alivira Animal Health Ltd. Recent Developments
9.2 Chempro Pharma Private Ltd.
9.2.1 Chempro Pharma Private Ltd. Company Information, Head Office, Market Area and Industry Position
9.2.2 Chempro Pharma Private Ltd. Company Profile and Main Business
9.2.3 Chempro Pharma Private Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
9.2.4 Chempro Pharma Private Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
9.2.5 Chempro Pharma Private Ltd. Recent Developments
9.3 Excel Industries Ltd.
9.3.1 Excel Industries Ltd. Company Information, Head Office, Market Area and Industry Position
9.3.2 Excel Industries Ltd. Company Profile and Main Business
9.3.3 Excel Industries Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
9.3.4 Excel Industries Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
9.3.5 Excel Industries Ltd. Recent Developments
9.4 FIS - Fabbrica Italiana Sintetici S.p.A.
9.4.1 FIS - Fabbrica Italiana Sintetici S.p.A. Company Information, Head Office, Market Area and Industry Position
9.4.2 FIS - Fabbrica Italiana Sintetici S.p.A. Company Profile and Main Business
9.4.3 FIS - Fabbrica Italiana Sintetici S.p.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
9.4.4 FIS - Fabbrica Italiana Sintetici S.p.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
9.4.5 FIS - Fabbrica Italiana Sintetici S.p.A. Recent Developments
9.5 HIKAL Ltd.
9.5.1 HIKAL Ltd. Company Information, Head Office, Market Area and Industry Position
9.5.2 HIKAL Ltd. Company Profile and Main Business
9.5.3 HIKAL Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
9.5.4 HIKAL Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
9.5.5 HIKAL Ltd. Recent Developments
9.6 HuBei Masteam Bio-tech
9.6.1 HuBei Masteam Bio-tech Company Information, Head Office, Market Area and Industry Position
9.6.2 HuBei Masteam Bio-tech Company Profile and Main Business
9.6.3 HuBei Masteam Bio-tech Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
9.6.4 HuBei Masteam Bio-tech Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
9.6.5 HuBei Masteam Bio-tech Recent Developments
9.7 Hunan Huateng Pharmaceutical
9.7.1 Hunan Huateng Pharmaceutical Company Information, Head Office, Market Area and Industry Position
9.7.2 Hunan Huateng Pharmaceutical Company Profile and Main Business
9.7.3 Hunan Huateng Pharmaceutical Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
9.7.4 Hunan Huateng Pharmaceutical Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
9.7.5 Hunan Huateng Pharmaceutical Recent Developments
9.8 Jiangsu Rivocean
9.8.1 Jiangsu Rivocean Company Information, Head Office, Market Area and Industry Position
9.8.2 Jiangsu Rivocean Company Profile and Main Business
9.8.3 Jiangsu Rivocean Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
9.8.4 Jiangsu Rivocean Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
9.8.5 Jiangsu Rivocean Recent Developments
9.9 Ofichem Group
9.9.1 Ofichem Group Company Information, Head Office, Market Area and Industry Position
9.9.2 Ofichem Group Company Profile and Main Business
9.9.3 Ofichem Group Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
9.9.4 Ofichem Group Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
9.9.5 Ofichem Group Recent Developments
9.10 Qilu Pharma Spain, S.A.
9.10.1 Qilu Pharma Spain, S.A. Company Information, Head Office, Market Area and Industry Position
9.10.2 Qilu Pharma Spain, S.A. Company Profile and Main Business
9.10.3 Qilu Pharma Spain, S.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
9.10.4 Qilu Pharma Spain, S.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
9.10.5 Qilu Pharma Spain, S.A. Recent Developments
9.11 Menadiona
9.11.1 Menadiona Company Information, Head Office, Market Area and Industry Position
9.11.2 Menadiona Company Profile and Main Business
9.11.3 Menadiona Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
9.11.4 Menadiona Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
9.11.5 Menadiona Recent Developments
9.12 Nissan Chemical
9.12.1 Nissan Chemical Company Information, Head Office, Market Area and Industry Position
9.12.2 Nissan Chemical Company Profile and Main Business
9.12.3 Nissan Chemical Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
9.12.4 Nissan Chemical Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
9.12.5 Nissan Chemical Recent Developments
9.13 SUANFARMA
9.13.1 SUANFARMA Company Information, Head Office, Market Area and Industry Position
9.13.2 SUANFARMA Company Profile and Main Business
9.13.3 SUANFARMA Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
9.13.4 SUANFARMA Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
9.13.5 SUANFARMA Recent Developments
9.14 Siflon Drugs
9.14.1 Siflon Drugs Company Information, Head Office, Market Area and Industry Position
9.14.2 Siflon Drugs Company Profile and Main Business
9.14.3 Siflon Drugs Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
9.14.4 Siflon Drugs Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
9.14.5 Siflon Drugs Recent Developments
9.15 Shaanxi Dideu Group
9.15.1 Shaanxi Dideu Group Company Information, Head Office, Market Area and Industry Position
9.15.2 Shaanxi Dideu Group Company Profile and Main Business
9.15.3 Shaanxi Dideu Group Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
9.15.4 Shaanxi Dideu Group Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
9.15.5 Shaanxi Dideu Group Recent Developments
9.16 Taizhou Crene Biotechnology
9.16.1 Taizhou Crene Biotechnology Company Information, Head Office, Market Area and Industry Position
9.16.2 Taizhou Crene Biotechnology Company Profile and Main Business
9.16.3 Taizhou Crene Biotechnology Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
9.16.4 Taizhou Crene Biotechnology Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
9.16.5 Taizhou Crene Biotechnology Recent Developments
9.17 Zhejiang Gihi Chemicals
9.17.1 Zhejiang Gihi Chemicals Company Information, Head Office, Market Area and Industry Position
9.17.2 Zhejiang Gihi Chemicals Company Profile and Main Business
9.17.3 Zhejiang Gihi Chemicals Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
9.17.4 Zhejiang Gihi Chemicals Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
9.17.5 Zhejiang Gihi Chemicals Recent Developments
9.18 Vetpharma (Insud Pharma, S.L.U)
9.18.1 Vetpharma (Insud Pharma, S.L.U) Company Information, Head Office, Market Area and Industry Position
9.18.2 Vetpharma (Insud Pharma, S.L.U) Company Profile and Main Business
9.18.3 Vetpharma (Insud Pharma, S.L.U) Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application
9.18.4 Vetpharma (Insud Pharma, S.L.U) Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023
9.18.5 Vetpharma (Insud Pharma, S.L.U) Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Tables & Figures:
Table 1. Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Restraints
Table 3. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Trends
Table 4. Veterinary Active Pharmaceutical Ingredients Manufacturing Industry Policy
Table 5. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Mergers & Acquisitions, Expansion Plans
Table 9. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Major Companies Product Type
Table 10. Head Office and Area Served of Key Players
Table 11. China Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 12. China Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share by Company, 2018-2023
Table 13. Global Key Players of Veterinary Active Pharmaceutical Ingredients Manufacturing Upstream (Raw Materials)
Table 14. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Typical Customers
Table 15. Veterinary Active Pharmaceutical Ingredients Manufacturing Typical Distributors
Table 16. By Type, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Application, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 19. By Region, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value, 2018-2029, US$ Million
Table 20. By Country, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 21. By Country, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value, 2018-2029, US$ Million
Table 22. By Country, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2018-2029
Table 23. Alivira Animal Health Ltd. Company Information, Head Office, Market Area and Industry Position
Table 24. Alivira Animal Health Ltd. Company Profile and Main Business
Table 25. Alivira Animal Health Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications, and Application
Table 26. Alivira Animal Health Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, US$ Million, 2018-2023
Table 27. Alivira Animal Health Ltd. Recent Developments
Table 28. Chempro Pharma Private Ltd. Company Information, Head Office, Market Area and Industry Position
Table 29. Chempro Pharma Private Ltd. Company Profile and Main Business
Table 30. Chempro Pharma Private Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications, and Application
Table 31. Chempro Pharma Private Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, US$ Million, 2018-2023
Table 32. Chempro Pharma Private Ltd. Recent Developments
Table 33. Excel Industries Ltd. Company Information, Head Office, Market Area and Industry Position
Table 34. Excel Industries Ltd. Company Profile and Main Business
Table 35. Excel Industries Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications, and Application
Table 36. Excel Industries Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, US$ Million, 2018-2023
Table 37. Excel Industries Ltd. Recent Developments
Table 38. FIS - Fabbrica Italiana Sintetici S.p.A. Company Information, Head Office, Market Area and Industry Position
Table 39. FIS - Fabbrica Italiana Sintetici S.p.A. Company Profile and Main Business
Table 40. FIS - Fabbrica Italiana Sintetici S.p.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications, and Application
Table 41. FIS - Fabbrica Italiana Sintetici S.p.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, US$ Million, 2018-2023
Table 42. FIS - Fabbrica Italiana Sintetici S.p.A. Recent Developments
Table 43. HIKAL Ltd. Company Information, Head Office, Market Area and Industry Position
Table 44. HIKAL Ltd. Company Profile and Main Business
Table 45. HIKAL Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications, and Application
Table 46. HIKAL Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, US$ Million, 2018-2023
Table 47. HIKAL Ltd. Recent Developments
Table 48. HuBei Masteam Bio-tech Company Information, Head Office, Market Area and Industry Position
Table 49. HuBei Masteam Bio-tech Company Profile and Main Business
Table 50. HuBei Masteam Bio-tech Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications, and Application
Table 51. HuBei Masteam Bio-tech Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, US$ Million, 2018-2023
Table 52. HuBei Masteam Bio-tech Recent Developments
Table 53. Hunan Huateng Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 54. Hunan Huateng Pharmaceutical Company Profile and Main Business
Table 55. Hunan Huateng Pharmaceutical Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications, and Application
Table 56. Hunan Huateng Pharmaceutical Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, US$ Million, 2018-2023
Table 57. Hunan Huateng Pharmaceutical Recent Developments
Table 58. Jiangsu Rivocean Company Information, Head Office, Market Area and Industry Position
Table 59. Jiangsu Rivocean Company Profile and Main Business
Table 60. Jiangsu Rivocean Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications, and Application
Table 61. Jiangsu Rivocean Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, US$ Million, 2018-2023
Table 62. Jiangsu Rivocean Recent Developments
Table 63. Ofichem Group Company Information, Head Office, Market Area and Industry Position
Table 64. Ofichem Group Company Profile and Main Business
Table 65. Ofichem Group Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications, and Application
Table 66. Ofichem Group Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, US$ Million, 2018-2023
Table 67. Ofichem Group Recent Developments
Table 68. Qilu Pharma Spain, S.A. Company Information, Head Office, Market Area and Industry Position
Table 69. Qilu Pharma Spain, S.A. Company Profile and Main Business
Table 70. Qilu Pharma Spain, S.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications, and Application
Table 71. Qilu Pharma Spain, S.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, US$ Million, 2018-2023
Table 72. Qilu Pharma Spain, S.A. Recent Developments
Table 73. Menadiona Company Information, Head Office, Market Area and Industry Position
Table 74. Menadiona Company Profile and Main Business
Table 75. Menadiona Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications, and Application
Table 76. Menadiona Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, US$ Million, 2018-2023
Table 77. Menadiona Recent Developments
Table 78. Nissan Chemical Company Information, Head Office, Market Area and Industry Position
Table 79. Nissan Chemical Company Profile and Main Business
Table 80. Nissan Chemical Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications, and Application
Table 81. Nissan Chemical Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, US$ Million, 2018-2023
Table 82. Nissan Chemical Recent Developments
Table 83. SUANFARMA Company Information, Head Office, Market Area and Industry Position
Table 84. SUANFARMA Company Profile and Main Business
Table 85. SUANFARMA Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications, and Application
Table 86. SUANFARMA Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, US$ Million, 2018-2023
Table 87. SUANFARMA Recent Developments
Table 88. Siflon Drugs Company Information, Head Office, Market Area and Industry Position
Table 89. Siflon Drugs Company Profile and Main Business
Table 90. Siflon Drugs Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications, and Application
Table 91. Siflon Drugs Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, US$ Million, 2018-2023
Table 92. Siflon Drugs Recent Developments
Table 93. Shaanxi Dideu Group Company Information, Head Office, Market Area and Industry Position
Table 94. Shaanxi Dideu Group Company Profile and Main Business
Table 95. Shaanxi Dideu Group Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications, and Application
Table 96. Shaanxi Dideu Group Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, US$ Million, 2018-2023
Table 97. Shaanxi Dideu Group Recent Developments
Table 98. Taizhou Crene Biotechnology Company Information, Head Office, Market Area and Industry Position
Table 99. Taizhou Crene Biotechnology Company Profile and Main Business
Table 100. Taizhou Crene Biotechnology Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications, and Application
Table 101. Taizhou Crene Biotechnology Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, US$ Million, 2018-2023
Table 102. Taizhou Crene Biotechnology Recent Developments
Table 103. Zhejiang Gihi Chemicals Company Information, Head Office, Market Area and Industry Position
Table 104. Zhejiang Gihi Chemicals Company Profile and Main Business
Table 105. Zhejiang Gihi Chemicals Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications, and Application
Table 106. Zhejiang Gihi Chemicals Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, US$ Million, 2018-2023
Table 107. Zhejiang Gihi Chemicals Recent Developments
Table 108. Vetpharma (Insud Pharma, S.L.U) Company Information, Head Office, Market Area and Industry Position
Table 109. Vetpharma (Insud Pharma, S.L.U) Company Profile and Main Business
Table 110. Vetpharma (Insud Pharma, S.L.U) Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications, and Application
Table 111. Vetpharma (Insud Pharma, S.L.U) Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, US$ Million, 2018-2023
Table 112. Vetpharma (Insud Pharma, S.L.U) Recent Developments
List of Figures
Figure 1. Veterinary Active Pharmaceutical Ingredients Manufacturing Picture
Figure 2. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value, (US$ million) & (2018-2029)
Figure 3. China Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value, (US$ million) & (2018-2029)
Figure 4. By Consumption Value, China Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share of Global, 2018-2029
Figure 5. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 6. China Veterinary Active Pharmaceutical Ingredients Manufacturing Key Participants, Market Share, 2022
Figure 7. Veterinary Active Pharmaceutical Ingredients Manufacturing Industry Chain
Figure 8. Veterinary Active Pharmaceutical Ingredients Manufacturing Procurement Model
Figure 9. Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Model
Figure 10. Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Channels, Direct Sales, and Distribution
Figure 11. Antiparasitic
Figure 12. Anti-infectives
Figure 13. NSAIDs
Figure 14. Others
Figure 15. By Type, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value, 2018-2029, US$ Million
Figure 16. By Type, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2018-2029
Figure 17. Companion Animals
Figure 18. Production/Food Animals
Figure 19. By Application, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value, 2018-2029, US$ Million
Figure 20. By Application, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2018-2029
Figure 21. By Region, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2018-2029
Figure 22. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 23. By Country, North America Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2022
Figure 24. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 25. By Country, Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2022
Figure 26. Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 27. By Country/Region, Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2022
Figure 28. South America Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 29. By Country, South America Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2022
Figure 30. Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 31. U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value, 2018-2029, US$ Million
Figure 32. By Type, U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2022 VS 2029
Figure 33. By Application, U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2022 VS 2029
Figure 34. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value, 2018-2029, US$ Million
Figure 35. By Type, Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2022 VS 2029
Figure 36. By Application, Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2022 VS 2029
Figure 37. China Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value, 2018-2029, US$ Million
Figure 38. By Type, China Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2022 VS 2029
Figure 39. By Application, China Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2022 VS 2029
Figure 40. Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value, 2018-2029, US$ Million
Figure 41. By Type, Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2022 VS 2029
Figure 42. By Application, Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2022 VS 2029
Figure 43. South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value, 2018-2029, US$ Million
Figure 44. By Type, South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2022 VS 2029
Figure 45. By Application, South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2022 VS 2029
Figure 46. Southeast Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value, 2018-2029, US$ Million
Figure 47. By Type, Southeast Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2022 VS 2029
Figure 48. By Application, Southeast Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2022 VS 2029
Figure 49. India Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value, 2018-2029, US$ Million
Figure 50. By Type, India Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2022 VS 2029
Figure 51. By Application, India Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2022 VS 2029
Figure 52. Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value, 2018-2029, US$ Million
Figure 53. By Type, Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2022 VS 2029
Figure 54. By Application, Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2022 VS 2029
Figure 55. Research Methodology
Figure 56. Breakdown of Primary Interviews
Figure 57. Bottom-up and Top-down Approaches
Figure 58. Top-down Approaches
Research Methodology:
Veterinary Active Pharmaceutical Ingredients Manufacturing Global and China Top Players Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|